5-Bromo-4-chlorothieno[2,3-d]pyrimidine

5-Bromo-4-chlorothieno[2,3-d]pyrimidine (CAS No.: 814918-95-1) functions primarily as a highly strategic, dual-reactive bicyclic intermediate and architectural core scaffold in organic synthesis and medicinal chemistry.

Privileged Scaffold for Adenosine Triphosphate (ATP) Mimics: The fused thienopyrimidine ring is a well-established privileged pharmacophore in drug discovery. This specific regioisomer is used to build powerful small-molecule tyrosine kinase inhibitors (TKIs) and phosphodiesterase (PDE) inhibitors. Because it acts as an ATP bioisostere, it fits precisely into the catalytic pockets of enzymes frequently mutated or overexpressed in cancers, such as EGFR, VEGFR-2, PI3K, or AKT.

Chemically Differentiated Late-Stage Functionalization Vectors: The defining functional advantage of this molecule is its placement of two distinct halogen leaving groups—a chlorine at the 4-position and a bromine at the 5-position. These two positions exhibit a steep reactivity gradient, enabling chemists to run highly selective, step-by-step modifications without cross-reactivity:

• C-4 Position Reactivity (Highly Active Chlorine): The chlorine atom on the electron-deficient pyrimidine ring is incredibly vulnerable to Nucleophilic Aromatic Substitution (\(\text{S}_\text{N}\text{Ar}\)). It is typically the first site to be functionalized, reacting smoothly under mild conditions with primary/secondary amines or substituted anilines to establish core hinge-binding interactions with target proteins.